The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 09, 2021

Filed:

Mar. 06, 2019
Applicant:

Sawai Pharmaceutical Co., Ltd., Osaka, JP;

Inventors:

Yoichi Higashiyama, Osaka, JP;

Wataru Izui, Osaka, JP;

Ayako Harada, Osaka, JP;

Satoru Ogihara, Osaka, JP;

Kenji Nozawa, Osaka, JP;

Hiroaki Kikuoka, Osaka, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/10 (2017.01); A61K 47/38 (2006.01); A61K 47/32 (2006.01); A61K 9/20 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/10 (2013.01); A61K 9/0056 (2013.01); A61K 9/20 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/2095 (2013.01); A61K 47/32 (2013.01); A61K 47/38 (2013.01);
Abstract

Provided is a novel additive for an orally disintegrating tablet providing quick disintegrability and tablet hardness to the orally disintegrating tablet, and a producing method therefor. According to an embodiment of the present invention, there is provided an additive for an orally disintegrating tablet characterized by including D-mannitol, low-substituted hydroxypropyl cellulose (however, excluding the low-substituted hydroxypropyl cellulose having a mean particle size of 20 μm or less and a substitution degree of hydroxypropoxy groups of 11%, a mean particle size of 45 μm or less and a substitution degree of hydroxypropoxy groups of 14%, and a mean particle size of 45 μm or less and a substitution degree of hydroxypropoxy groups of 11% and a 90% cumulated particle size of 100 μm or less), crospovidone, and microcrystalline cellulose, wherein the low-substituted hydroxypropyl cellulose and the crospovidone are included in a ratio of 5:4.


Find Patent Forward Citations

Loading…